Expression of cell-cell interacting genes distinguishes HLXB9/TEL from MLL-positive childhood acute myeloid leukemia

Leukemia

Volumn 24, Issue 9, 2010, Pages 1657-1660

  Wildenhain, S ^a   Ruckert, C ^b   Rottgers S ^c   Harbott, J ^c   Ludwig, W D ^d   Schuster, F R ^a   Beldjord, K ^e   Binder, V ^a   Slany, R ^f   Hauer, J ^a   Borkhardt, A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d HELIOS Clinic   (Germany)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HLXB9; UNCLASSIFIED DRUG; MLL PROTEIN, HUMAN; MNX1 PROTEIN, HUMAN; PRIMER DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGRESSION; CANCER RELAPSE; CELL INTERACTION; CHILD; CHILDHOOD LEUKEMIA; DOWN REGULATION; EVENT FREE SURVIVAL; GENE EXPRESSION; GENE LOCUS; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; LETTER; LEUKEMIA CELL; MUTATION; ONSET AGE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TREATMENT OUTCOME; UPREGULATION; GENETICS; INFANT; KARYOTYPING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

BASE SEQUENCE; DNA PRIMERS; HOMEODOMAIN PROTEINS; HUMANS; INFANT; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 77956426495     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.146     Document Type: Letter

References (7)

1. Krivtsov AV, Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 2007; 7: 823-833.
2. Hauer J, Tosi S, Schuster FR, Harbott J, Kolb HJ, Borkhardt A. Graft versus leukemia effect after haploidentical HSCT in a MLL-negative infant AML with HLXB9/ETV6 rearrangement. Pediatr Blood Cancer 2008; 50: 921-923.
3. von Bergh AR, van Drunen E, van Wering ER, van Zutven LJ, Hainmann I, Lönnerholm G et al. High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9. Genes Chromosomes Cancer 2006; 45: 731-739.
4. Currarino G, Coln D, Votteler T. Triad of anorectal, sacral, and presacral anomalies. Am J Roentgenol 1981; 137: 395-398.
5. Wada H, Masuda K, Satoh R, Kakugawa K, Ikawa T, Katsura Y et al. Adult T-cell progenitors retain myeloid potential. Nature 2008; 452: 768-772.
6. Zangrando A, Dellorto MC, Te Kronnie G, Basso G. MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures. BMC Med Genomics 2009; 2: 36.
7. Renstrom J, Kroger M, Peschel C, Oostendorp RA. How the niche regulates hematopoietic stem cells. Chem Biol Interact 2010; 19: 7-15